在一个随机的安慰剂控制的交叉试验中,大麻素用于急性治疗失眠障碍
Isobel G Lavender1,2,3, Nathaniel S Marshall1,4, Danielle McCartney1,2,3
1Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia.
Journal of sleep research
|February 16, 2026
概括
在患有失眠障碍的成年人中,大麻素并没有显著改善睡眠开始或减少清醒. 然而,300毫克的剂量改善了睡眠质量,并减少了睡眠唤醒.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 失眠症严重影响健康,需要创新的治疗策略.
- 大麻素 (CBN) 是 Δ9-四化大麻素的衍生物,有传闻称它具有催眠性质,但它对睡眠和失眠的客观影响仍然未经证实.
研究的目的:
- 调查大麻素 (CBN) 作为治疗失眠障碍的急性疗效和安全性.
- 评估单次口服大麻素剂量对通过多睡眠学测量的客观睡眠参数的影响.
主要方法:
- 进行了一项随机,双盲,安慰剂控制,三臂,单夜交叉试验.
- 20名被诊断患有失眠障碍的成年人接受了30毫克或300毫克的卡纳比诺尔或安慰剂.
- 作为首要结局,使用过夜的多睡眠记录来测量睡眠开始后的觉醒 (WASO).
主要成果:
- 在患有失眠障碍的参与者中,大麻素没有显著改变WASO.
- 300mg大麻素剂量显著增加了非快速眼动-2睡眠和主观睡眠质量.
- 随着300mg的剂量,睡眠开始延迟和电脑图唤醒指数的显著减少被观察到.
结论:
- 单剂量大麻素并没有显著改善成年人失眠障碍的客观睡眠连续性.
- 较高剂量的 cannabinol 显示在提高睡眠质量和减少睡眠障碍方面具有潜在的益处.
- 建议通过更大,更长时间的试验进行进一步的研究,以充分确定大麻素对失眠的治疗潜力.
相关概念视频
Management of Insomnia
688
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
688
Insomnia
507
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
507
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
804
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
804
Substance Use Disorders Affecting Sleep
463
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
463
Sedatives and Hypnotics Drugs: Miscellaneous Agents
633
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
633
CNS Depressants: Barbiturates and Benzodiazepines
1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K


